Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them?

Antisense and Nucleic Acid Drug Development

Volumn 10, Issue 2, 2000, Pages 117-121

  Eckstein, Fritz ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE TRIPHOSPHATE; NUCLEASE; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID;

PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0034015113     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.2000.10.117     Document Type: Review

References (42)

1. AGRAWAL, S., GOOCHILD, J., CIVEIRA, M.P., THORNTON, A.H., SARIN, P.S., and ZAMECNIK, P.C. (1988). Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85, 7079-7083.
2. BACHELIN, M., HESSLER, G., KURZ, G., HACIA, J.G., DERVAN, P.B., and KESSLER, H. (1998). Structure of a stereoregular phosphorothioate DNA/RNA duplex. Nature Struct. Biol. 5, 271-276.
3. BARANIAK, J., and FREY, P.A. (1988). Effect of ion pairing on bond order and charge localization in alkyl phosphorothioates. J. Am. Chem. Soc. 110, 4059-4060.
4. BOND, M.D., HOLMQUIST, B., and VALLEE, B.L. (1986). Thioamide substrate probes of metal-substrate interactions in carboxypeptidase A catalysis. J. Inorg. Biochem. 28, 97-105.
5. BRAUTIGAM, C.A., and STEITZ, T.A. (1998). Structural principles for the inhibition of the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I by phosphorothioates. J. Mol. Biol. 277, 363-377.
6. BURGERS, P.M.J., and ECKSTEIN, F. (1978). Synthesis of dinucleoside monophosphorothioates via addition to sulfur to phosphite triesters. Tetrahedron Lett. 3835-3838.
7. CONNOLLY, B.A., POTTER, B.V., ECKSTEIN, F., PINGOUD, A., and GROTJAHN, L. (1984). Synthesis and characterization of an octanucleotide containing the EcoRI recognition sequence with a phosphorothioate group at the cleavage site. Biochemistry 23, 3443-3453.
8. CRUSE, W.B.T., SALISBURY, S.A., BROWN, T., COSSTICK, R., ECKSTEIN, F., and KENNARD, O. (1986). Chiral phosphorothioate analogues of B-DNA: The crystal structure of Rpd[Gp(S)CpGp(S)C]. J. Mol. Biol. 192, 891-905.
9. DE CLERCQ, E., ECKSTEIN, F., and MERIGAN, T.C. (1969). Interferon induction increased through chemical modification of a synthetic polyribonucleotide. Science 165, 1137-1139.
10. DE CLERCQ, E., ECKSTEIN, F., STERNBACH, H., and MERIGAN, T.C. (1970). The antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo. Virology 42, 421-428.
11. ECKSTEIN, F. (1966). Nucleoside phosphorothioates. J. Am. Chem. Soc. 4292-4293.
12. ECKSTEIN, F. (1967a). A dinucleoside phosphorothioate. Tetrahedron Lett. 1157-1160.
13. ECKSTEIN, F. (1967b). Diuridin-3′,5′thiophosphate. Tetrahedron Lett. 3495-3499.
14. ECKSTEIN, F. (1985). Nucleoside phosphorothioates. Annu. Rev. biochem. 54, 367-402.
15. ECKSTEIN, F., and GINDL, H. (1969). Polyribonucleotides containing a thiophosphate backbone. FEES Lett. 2, 262-264.
16. FURRER, P., BILLECI, T.M., DONATI, A., KOJIMA, C., KARWOWSKI, B., SIERZCHALA, A., STEC, W., and JAMES, T.L. (1999). Structural effect of complete [Rp]-phosphorothioate and phosphorodithioate substitutions in the DNA strand of a model antisense inhibitor-target RNA complex. J. Mol. Biol. 285, 1609-1622.
17. IYER, R.P., GUO, M.-J. YU, D., and AGRAWAL, S. (1998). Solid-phase stereoselective synthesis of oligonucleoside phosphorothioates: The nucleoside bicyclic oxazaphospholidines as novel synthons. Tetrahedron Lett. 39, 2491-2494.
18. KUNKEL, T.A., ECKSTEIN, F., MILDVAN, A.S., KOPLITZ, R.M., and LOEB, L.A., (1981). Deoxynucleoside [1-thio] triphosphates prevent proofreading during in vitro DNA synthesis. Proc. Natl. Acad. Sci. USA 78, 6734-6738.
19. LEE, M., SIMON, A.D., STEIN, C.A., and RABBANI, L.E. (1999). Antisense strategies to inhibit restenosis. Antisense Nucleic Acid Drug Dev. 9, 487-492.
20. LIANG, C., and ALLEN, L.C. (1987). Sulfur does not form double bonds in phosphorothioate anions. J. Am. Chem. Soc. 109, 6449-6453.
21. MATSUKURA, M., SHINOZUKA, K., ZON, G., MITSUYA, H., REITZ, M., COHEN, J., and BRODER, S. (1987). Phosphorothioate analogues of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84, 7706-7710.
22. MATZURA, H., and ECKSTEIN, F. (1968). A polyribonucleotide containing alternating P=O and P=S linkages. Eur. J. Biochem. 3, 448-452.
23. NAKAMAYE, K., and ECKSTEIN, F. (1986). Inhibition of restriction endonculease NciI cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14, 9679-9698.
24. NOEL, J.P., HAMM, H.E., and SIGLER, P.B. (1993). The 2.2 Å crystal structure of transducin-α complexed with GTPγS. Nature 366, 654-663.
25. rd ed. (Cornell University Press, Ithaca, NY), p. 200.
26. PEARSON, R.G. (1966). Acids and bases. Science 151, 172-177.
27. 2+ complexes of adenine nucleotides and thionucleotides and rate constants for formation and dissociation of MgATP and MgADP. Biochemistry 23, 5262-5271.
28. PHILLIPS, M.I., ed. (2000a). Methods Enzymol. 13.
29. PHILLIPS, M.I., ed. (2000b). Methods Enzymol. 14.
30. POLESKY, A.H., DAHLBERG, M.E., BENKOVIC, S.J., GRINDLEY, N.D.F., and JOYCE, C.M. (1992). Side chains involved in catalysis of the polymerase reaction of DNA polymerase I from Escherichia coli. J. Biol. Chem. 267, 8417-8428.
31. SAENGER, W., and ECKSTEIN, F. (1970). Stereochemistry of a substrate for pancreatic ribonuclease. Crystal and molecular structure of the triethylammonium salt of undine 2′,3′-O,O-cyclophosphorothioate. J. Am. Chem. Soc. 94, 4712-4718.
32. SAYERS, J.R., SCHMIDT, W., and ECKSTEIN, F. (1988). 5′-3′-Exonucleases in phosphorothioate-based oligonculeotide-directed mutagenesis. Nucleic Acids Res. 16, 791-802.
33. SPITZER, S., and ECKSTEIN, F. (1988). Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides. Nucleic Acids Res. 16, 11691-11704.
34. STEC, W.J., CIERNIEWSKI, C.S., OKRUSZEK, A., KOBYLANSKA, A., PAWLOWSKA, Z., KOZIOLKEWICZ, M., PLUSKOTA, E., MACIASZEK, A., REBOWSKA, B., and STASIAK, M. (1997). Sterodependent inhibition of plasminogen activator inhibitor type 1 by phosphorothioate oligonucleotides: Proof of sequence specificity in cell culture and in vivo rat experiments. Antisense Nucleic Acid Drug Dev. 7, 567-573.
35. STEC, W.J., KARWOWSKI, B., BOCZKOWSKA, M., GUGA, P., KOZIOLKIEWICZ, M., SOCHAKI, M., WIECZOREK, M.W., and BLASZCZYK, J. (1998). Deoxyribonucleoside 3′O-(2-thio- and 2-oxo-"spiro"-4,4-pentamethylene-1,2,3-oxathiaphospholane)s: Monomers for stereocontrolled synthesis of oligo(deoxyribonucleoside phosphorothioate)s and chimeric PS/PO oligonucleotides. J. Am. Chem. Soc. 120, 7156-7167.
36. STEC, W.J., ZON, G., EGA, W., and STEC, B. (1984). Automated solid-phase synthesis, separation and stereochemistry of phosphorothioate analogues of oligodeoxynucleotides. J. Am. Chem. Soc. 106, 6077-6089.
37. STEC, W.J., ZON, G., and UZNANSKI, B. (1985). Reverse-phase HPLC separation of diastereomeric phosphorothioate analogues of oligonucleotides and other back-bone modified congeners of DNA. J. Chromatogr. 236, 263-280.
38. STEITZ, T.A., and STEITZ, J.A. (1993). A general two-metal ion mechanism for catalytic RNA. Proc. Natl. Acad. Sci. USA 90, 6498-6502.
39. TAYLOR, J.W., OTT, J., and ECKSTEIN, F. (1985a). The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate DNA. Nucleic Acids Res. 13, 8765-8785.
40. TAYLOR, J.W., SCHMIDT, W., COSSTICK, R., OKRUZEK, A., and ECKSTEIN, F. (1985b). The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA. Nucleic Acids Res. 13, 8749-8764.
41. THOROGOOD, H., GRASBY, J.A., and CONNOLLY, B.A. (1996). Influence of the phosphate backbone on the recognition and hydrolysis of DNA by the EcoRV restriction endonuclease. J. Biol. Chem. 271, 8855-8862.
42. VERMA, S., and ECKSTEIN, F. (1998). Modified oligonucleotides: Synthesis and strategy for users. Annu. Rev. Biochem. 67, 99-134.